Skip to main content

Scaling up the WHO-PEN package for diabetes and hypertension in Swaziland: a nation-wide cluster-randomised evaluation of three strategies in Swaziland (WHO-PEN@Scale)

Objective

Swaziland has a very high prevalence of both diabetes and hypertension, with the majority of those affected being undiagnosed. Like many other countries in sub-Saharan Africa (SSA), however, Swaziland provides care for diabetes and hypertension only through physician-led teams in hospitals. The country has recently conducted a successful feasibility pilot of the World Health Organisation’s Package of Essential NCD Interventions for Primary Health Care in low-resource settings (WHO-PEN). The WHO-PEN@Scale project aims to improve diabetes and hypertension control at the population-level by helping Swaziland identify and scale up the most effective healthcare delivery model for WHO-PEN implementation at scale. Specifically, we will conduct an innovative nation-wide three-phased adaptive randomised study to i) rigorously assess the effectiveness and cost-effectiveness of three novel community-based healthcare delivery models to scale up WHO-PEN for diabetes and hypertension nationally, ii) study in-depth the real-life implementation of the WHO-PEN national scale-up in Swaziland to generate lessons for other countries, and iii) actively disseminate the Swazi experience along with an open-source toolkit for WHO-PEN scale-up to policy makers in SSA. WHO-PEN@Scale will therefore provide a blueprint of primary health system strengthening for diabetes and hypertension – and ultimately non-communicable diseases (NCDs) more generally - for other countries in the region. WHO-PEN@Scale is highly relevant to this work programme because i) the interventions contained in WHO-PEN have been shown to be cost-effective, ii) the scale-up is government-led, and iii) we assess the impact of WHO-PEN@Scale on diabetes and hypertension control at the population-level.

Field of science

  • /medical and health sciences/clinical medicine/endocrinology/diabetes

Call for proposal

H2020-SC1-2018-Single-Stage-RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

UNIVERSITATSKLINIKUM HEIDELBERG
Address
Im Neuenheimer Feld 672
69120 Heidelberg
Germany
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 648 750

Participants (8)

SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT
Switzerland
EU contribution
€ 262 696,25
Address
Socinstrasse 57
CH-4002 Basel
Activity type
Research Organisations
UNIVERSITY OF SWAZILAND
Eswatini
EU contribution
€ 218 750
Address
Kwaluseni
M201 Mazini
Activity type
Higher or Secondary Education Establishments
STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT
Netherlands
EU contribution
€ 459 335
Address
Paasheuvelweg 25 Tower C4
1105 BP Amsterdam
Activity type
Research Organisations
GEORG-AUGUST-UNIVERSITAT GOTTINGENSTIFTUNG OFFENTLICHEN RECHTS
Germany
EU contribution
€ 320 070
Address
Wilhelmsplatz 1
37073 Gottingen
Activity type
Higher or Secondary Education Establishments
FOLKEHELSEINSTITUTTET
Norway
EU contribution
€ 224 018,25
Address
Lovisenberggata 8
0456 Oslo
Activity type
Research Organisations
CLINTON HEALTH ACCESS INITIATIVE
United States
EU contribution
€ 1 222 042,50
Address
383 Dorchester Avenue Suite 400
02127 Boston
Activity type
Other
DIABETES SWAZILAND
Eswatini
EU contribution
€ 37 500
Address
Po Box 6820
M200 Manzini
Activity type
Other
SWAZILAND BUSINESS COALITION ON HIVAND AIDS
Eswatini
EU contribution
€ 56 250
Address
Matsapha Crescent Matsapha Industrial Site
M202 Matsapha
Activity type
Other